Therapy Areas: Hereditary Disorders
18 September 2017 - - Austin, Texas-based mechanical oscillation vest therapy developer International Biophysics Corp. has introduced its next generation AffloVest fully mobile respiratory HFCWO (High...
25 August 2017 - - Applications by Boston, Massachusetts-based serious disease therapeutics developer Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) for the use of the tezacaftor/ivacaftor combination tre...
25 August 2017 - British pharmaceutical firm Vertex's experimental tezacaftor/ivacaftor combination therapy for cystic fibrosis is currently being reviewed by regulators on both sides of the Atla...
3 August 2017 - - San Jose, California-based anti-infectives and immunotherapies specialist Aridis Pharmaceuticals, Inc. is actively enrolling patients in a global pivotal study of Aerucin, the compan...
1 August 2017 - - US-based gastrointestinal disorder and rare disease treatment developer Alcresta Therapeutics, Inc. has published data from a pivotal clinical study of their product Relizorb, a nove...
28 July 2017 - - Hayward, California-based respiratory disease treatment developer Aradigm Corp. (NASDAQ: ARDM) has submitted its new drug application to the US Food and Drug Administration for Linhal...